Page last updated: 2024-08-16

ribavirin and Coagulation Disorders, Blood

ribavirin has been researched along with Coagulation Disorders, Blood in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belleli, D; Davis, AK; Kemp, W; McCarthy, P; Northcott, MJ; Ong, WL; Street, A; Tran, H; Walsh, M1
Goto, H; Hayashi, K; Hirooka, Y; Honda, T; Ishigami, M; Ishikawa, T; Itoh, A; Katano, Y; Kojima, T; Kumada, T; Kuzuya, T; Matsushita, T; Nakano, I; Takamatsu, J; Toyoda, H; Yamamoto, K1
Haagsma, EB; Meijer, K; van der Meer, J1
De Heusden, N; Fischer, K; Mauser-Bunschoten, EP; Posthouwer, D1
Adams, PC; Bain, VG; Chatterjee, A; Croitoru, K; Heathcote, EJ; Kaita, K; Lee, SS; Peltekian, K; Swain, MG; Teitel, J1
Altisent, C; Esteban, JI; Esteban, R; Guardia, J; Puig, L; Sauleda, S1
Altisent, C; Esteban, JI; Esteban, R; Guardia, J; Juárez, A; Puig, L; Ruiz, I; Sauleda, S1
Kinnman, N; Lindmarker, P; Schulman, S; von Sydow, M1

Trials

4 trial(s) available for ribavirin and Coagulation Disorders, Blood

ArticleYear
A randomized, double-blind, placebo-controlled clinical trial of high-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in hemophilia.
    Journal of thrombosis and haemostasis : JTH, 2004, Volume: 2, Issue:1

    Topics: Adolescent; Adult; Antiviral Agents; Blood Coagulation Disorders; Double-Blind Method; Drug Therapy, Combination; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Recombinant Proteins; Ribavirin

2004
Induction versus noninduction antiviral therapy for chronic hepatitis C virus in patients with congenital coagulation disorders: a Canadian multicentre trial.
    Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2007, Volume: 21, Issue:2

    Topics: Adult; Antiviral Agents; Blood Coagulation Disorders; Canada; Comorbidity; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; RNA, Viral

2007
Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders.
    Hepatology (Baltimore, Md.), 2001, Volume: 34, Issue:5

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Blood Coagulation Disorders; Drug Therapy, Combination; Female; Hemoglobins; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome

2001
A randomized study of alpha-interferon plus ribavirin for 6 months or 12 months for the treatment of chronic hepatitis C in patients with bleeding disorders.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2002, Volume: 8, Issue:2

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Blood Coagulation Disorders; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; Treatment Outcome

2002

Other Studies

4 other study(ies) available for ribavirin and Coagulation Disorders, Blood

ArticleYear
Prevalence of transfusion-acquired hepatitis C in an Australian bleeding disorders population.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2013, Volume: 19, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Australia; Blood Coagulation Disorders; Blood Transfusion; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C Antibodies; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Prevalence; Recombinant Proteins; Retrospective Studies; Ribavirin; Transfusion Reaction; Young Adult

2013
Comparison of the efficacy of ribavirin plus peginterferon alfa-2b for chronic hepatitis C infection in patients with and without coagulation disorders.
    Journal of medical virology, 2013, Volume: 85, Issue:2

    Topics: Adult; Aged; Antiviral Agents; Blood Coagulation Disorders; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Young Adult

2013
Pegylated interferon and ribavirin combination therapy for chronic hepatitis C in patients with congenital bleeding disorders: a single-centre experience.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2007, Volume: 13, Issue:1

    Topics: Adolescent; Adult; Antiviral Agents; Blood Coagulation Disorders; Combined Modality Therapy; Depression; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load

2007
Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C.
    Thrombosis and haemostasis, 2000, Volume: 83, Issue:6

    Topics: Adolescent; Adult; Age Factors; Age of Onset; Alanine Transaminase; Antiviral Agents; Blood Coagulation Disorders; Child; Chronic Disease; Drug Therapy, Combination; Factor VII Deficiency; Female; Hemoglobins; Hemophilia A; Hemophilia B; Hepacivirus; Hepatitis C; HIV Antibodies; HIV Seronegativity; Humans; Interferons; Male; Middle Aged; Neutrophils; Platelet Count; Predictive Value of Tests; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Sensitivity and Specificity; Treatment Outcome; von Willebrand Diseases

2000